Immune Response, Safety, and Survival and Quality of Life Outcomes for Advanced Colorectal Cancer Patients Treated with Dendritic Cell Vaccine and Cytokine-Induced Killer Cell Therapy

Table 1

Patient characteristics.

Characteristics	No. (%)			𝑃
	Total	Group I	Group NI
No.	351	100	251
Age (years)
Range	19–92	25–85	19–92	0.47
Mean ± SD	65.9±13.2	62.1±12.4	67.4±13.2
Gender
Male	229 (65.2)	71 (71.0)	158 (62.9)	0.15
Female	122 (34.8)	29 (29.0)	93 (37.1)
Tumor location
Colon	108 (30.8)	29 (29.0)	79 (31.5)	0.65
Rectum	243 (69.2)	71 (71.0)	172 (68.5)
Treatment baseline
Surgery	73 (20.8)	28 (28.0)	45 (17.9)	0.04
Radiotherapy	29 (8.3)	8 (8.0)	21 (8.4)	0.91
Chemotherapy	55 (15.7)	18 (18.0)	37 (14.7)	0.45